Over 3 years ago in this Journal, we published a meta-analysis that compared the ability of standard dressings to that of closed-incision negative-pressure therapy (ciNPT) in reducing the chances of surgical site infections. The authors concluded that ciNPT was a potentially effective way to reduce site infections and also reduce dehiscence.1 This was a very timely study, since the Centers for Disease Control had reported more than 157,000 surgical site infections for inpatient procedures in the United States alone,2 and the medical community was in need of new technologies to help reduce these types of infections. In the years since, there has been more and more research coming out on potential clinical applications for ciNPT, including studies in our journals that reported on its use in immediate postmastectomy breast reconstruction,3 in general oncological breast surgery,4 and in abdominal wall reconstruction.5 Wound healing technology and its potential uses grow every day, and our readers need to stay informed of the most up-to-date information and critical peer-reviewed research and reviews on this topic. With that in mind, I present this special supplement to Plastic and Reconstructive Surgery on “Management of Surgical Incisions Utilizing Closed Incision Negative Pressure Therapy (ciNPT).” This special multidisciplinary edition provides meaningful follow-up and insights into the use of ciNPT in plastic surgery and beyond, examining the effects of the technology in aesthetics, orthopedics, obstetrics, cardiothoracic surgery, and breast reconstruction. You will also find a meta-analysis of comparative trials and an examination of the challenges and management of surgical site occurrences. I know you will find this supplement thought-provoking, informational, and engaging; it is coming as the science of wound healing and ciNPT continues to evolve at the speed of science and the potential impact on the healthcare system and quality of care are truly coming into focus.
The techniques presented in this supplement to Plastic and Reconstructive Surgery do not necessarily represent best practices or endorsed techniques of the Guest Editors, Editor-in-Chief, Editorial Board, American Society of Plastic Surgeons (ASPS), or Wolters Kluwer Health. Publication of these supplements does not constitute product or sponsor endorsement by this Journal or the ASPS. This supplement was made possible by a sponsorship from KCI, an Acelity Company. Advisors, investigators, and consultants to Acelity may have served as authors on the chapters herein, as allowed by the ASPS Supplement Publication Policy; all authors are listed on the manuscripts as authors or acknowledged participators, as PRS does not support ghost writing. As with all Plastic and Reconstructive Surgery articles, financial disclosure statements are provided for each article and, with all supplements, they are intentionally and redundantly included as an appendix, for your convenience. None of the materials contained in this supplement are considered to be practice guidelines or best medicine protocols but are merely the authors’ collective experience and expertise in the prescribed area. These articles have been rigorously peer-reviewed and revised before acceptance.
I am very grateful for the hard work, inspiration, and leadership of this supplement’s guest editors, Allen Gabriel, MD, G. Patrick Maxwell, MD, and Dennis Orgill, MD, who helped shepherd this supplement from inception to fruition.
I would also like to thank our robust, multidisciplinary panel of authors and peer-reviewers, including experts from the fields of plastic and reconstructive surgery, obstetrics, cardiothoracic and vascular surgery, and oncoplastic surgery. These women and men worked tirelessly on tight timelines, and maintained poise and composure as they gave their insights on this important wide-reaching topic. This supplement would not have been possible without them.
As indicated previously, the publication of this supplement was made possible by a sponsorship from KCI, an Acelity Company. On behalf of the ASPS Executive Committee, the PRS and PRS Global Open Managing Committee, and the PRS Editorial Board, I would like to thank this supporter for their dedication to advancing the plastic surgery literature. All financial declarations/affiliations of the authors have been intentionally and redundantly disclosed and printed in this supplement.
Finally, I am grateful for our gifted and resolute publishing team at Wolters Kluwer Health, especially Jeda Taylor, our Senior Production Editor, and the amazing Editorial Office team, especially Editorial Coordinator Christina Carson and Senior Managing Editor Aaron Weinstein. The Editorial and Publishing team’s dependability, dedication, accuracy, and dynamism help us continually make PRS the number 1 journal in the field.
1. Semsarzadeh NN, Tadisina KK, Maddox J, et al. Closed incision negative-pressure therapy is associated with decreased surgical-site infections: a meta-analysis. Plast Reconstr Surg. 2015;136:592602.
2. Magill SS, Edwards JR, Bamberg W, et al. Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370:11981208.
3. Gabriel A, Sigalove SR, Maxwell GP. Initial experience using closed incision negative pressure therapy after immediate postmastectomy breast reconstruction. Plast Reconstr Surg Glob Open. 2016;4:e819.
4. Ferrando PM, Ala A, Bussone R, et al. Closed incision negative pressure therapy in oncological breast surgery: comparison with standard care dressings. Plast Reconstr Surg Glob Open. 2018;6:e1732.
5. Sinh D. The role of closed incision negative pressure therapy in abdominal wall reconstruction: a current review of the evidence. Plast Reconstr Surg. 2018;142:156S162S.